Preclinical NASH models implicate TSP1 in the modulation of NAFLD/NASH with evidence that Thbs1−/− mice fed a choline-deficient L-amino acid-defined high-fat diet were protected from the liver damage associated with NASH [12]. Here, THBS1 is linked to metabolic dysfunction-associated steatohepatitis.